Demetrios Vavvas is an Ophthalmology physician affiliated with Massachusetts Eye and Ear Infirmary. OpenAlex indexes 520 publications with 20,621 citations (h-index 57). By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
243 Charles St
Boston, MA 021143002
Telephone
617-573-5589Registry record last updated 17 Apr 2009.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sumitomo Pharma America, Inc.Program year20252 payments$33,000openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202511 payments
- Alcon Vision LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
52.1%Cyclooxygenase Inhibitor52.1%Ketorolac Tromethamine100%Part D≥23 patientsSensory organs
47.9%Corticosteroid35.1%Prednisolone Acetate100%Part D≥16 patientsalpha-Adrenergic Agonist12.8%Brimonidine Tartrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2013–2020 per NIH RePORTER. The latest:
- 4th Harvard Biennial International Ocular Regeneration Symposium: From Bench to Bedside
Massachusetts Eye and Ear Infirmary
FY2020$24,000R13EY031922 - Necroptosis, neuroprotection and axonal regeneration in retina ganglion cell injury
Massachusetts Eye and Ear Infirmary
FY2018$369,000R01EY025362 - The Third International Biennial Symposium on Ocular Regeneration: Tissue Engineering and the Eye
Massachusetts Eye and Ear Infirmary
FY2018$24,000R13EY029551
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)
Progress in Retinal and Eye Research
2021 - CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages
Proceedings of the National Academy of Sciences
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Dean Eliott, MD
Massachusetts Eye and Ear Infirmary
Daniel Liebman, MD
Massachusetts Eye and Ear Infirmary
Neil Bhattacharyya, MD, FACS
Massachusetts Eye and Ear Infirmary
Evangelos Gragoudas, MD
Massachusetts Eye and Ear Infirmary
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”